Caring Brands (CABR) Long-Term Deferred Tax (2024 - 2025)
Caring Brands' (CABR) quarterly Long-Term Deferred Tax came in at $647029.0 in Q3 2025, up 257.11% quarter-over-quarter from $181186.0 in Q4 2024.
Caring Brands (CABR) Long-Term Deferred Tax (2024 - 2025) Analysis & Trends
Caring Brands' Long-Term Deferred Tax history runs 2 years deep, the most recent figure standing at $647029.0 for Q3 2025.
- On a quarterly basis, Long-Term Deferred Tax changed N/A year-over-year to $647029.0 in Q3 2025; TTM through Sep 2025 was $647029.0, a N/A change from a year earlier, with the FY2024 full-year figure at $181186.0, changed N/A from the prior year.
- Long-Term Deferred Tax advanced to $647029.0 in Q3 2025 per CABR's latest filing, from $181186.0 in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $647029.0 in Q3 2025 and bottomed at $181186.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Caring Brands | 20.08 Mn | 21.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 647,029.00 |
| Dec 31, 2024 | 181,186.00 |